3'-N-methyl-3'-N-(3-aminopropyl)-4"-O-(3-diethylaminopropionyl)-6-O-methyl-9a-aza-9a-homoerythromycin A | 906453-17-6

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 3'-N-methyl-3'-N-(3-aminopropyl)-4"-O-(3-diethylaminopropionyl)-6-O-methyl-9a-aza-9a-homoerythromycin A
• 英文别名: [(2S,3S,4R,6R)-6-[[(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-[3-aminopropyl(methyl)amino]-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4-dihydroxy-10-methoxy-3,5,8,10,12,14-hexamethyl-7,15-dioxo-1-oxa-6-azacyclopentadec-13-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl] 3-(diethylamino)propanoate
• CAS: 906453-17-6
• 化学式: C₄₇H₈₈N₄O₁₄
• 分子量: 933.234
• InChiKey: PCSHMDGCUMNDFI-XLHDBUMYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  65
• 可旋转键数：
  18
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.94
• 拓扑面积：
  230
• 氢给体数：
  5
• 氢受体数：
  17

反应信息

• 作为产物：
  描述：

  3'-N-demethyl-6-O-methyl-9a-aza-9a-homoerythromycin A 在 platinum(IV) oxide 氢气 、 三乙胺 作用下， 以 溶剂黄146 、 异丙醇 为溶剂， 70.0 ℃ 、500.01 kPa 条件下， 生成 3'-N-methyl-3'-N-(3-aminopropyl)-4"-O-(3-diethylaminopropionyl)-6-O-methyl-9a-aza-9a-homoerythromycin A
  参考文献：
  名称：

  Macrolides With Anti-Inflammatory Activity

  摘要：

  本发明涉及具有抗炎活性的新型半合成大环内酯类化合物。更具体地说，该发明涉及在4″位置取代的14-和15-环大环内酯类化合物，及其药学上可接受的衍生物，用于其制备的工艺和中间体，含有它们的制剂，以及它们在治疗人类和动物的炎症性疾病和症状中的活性和用途，特别是那些与过度分泌TNF-α、IL-1、IL-8、IL-2或IL-5有关的疾病；和/或抑制过度淋巴细胞增殖；和/或过度粒细胞脱颗粒的抑制剂。

  公开号：

  US20080221046A1

文献信息

• Macrolides with Anti-Inflammatory Activity
  申请人：Alihodzic Sulejman

  公开号：US20120058963A1

  公开（公告）日：2012-03-08

  The present invention relates to novel semi-synthetic macrolides having anti-inflammatory activity. More particularly, the invention relates to 14- and 15-membered macrolides substituted at the 4″ position, to their pharmaceutically acceptable derivatives, to processes and intermediates for their preparation, to pharmaceutical compositions containing them and to their activity and use in the treatment of inflammatory diseases and conditions in humans and animals, especially those diseases associated with excessive secretion of TNF-α, IL-1, IL-8, IL-2 or IL-5; and/or inhibitor of excessive lymphocyte proliferation; and/or excessive granulocyte degranulation.
• US8080529B2
  申请人：——

  公开号：US8080529B2

  公开（公告）日：2011-12-20
• Macrolides With Anti-Inflammatory Activity
  申请人：Culic Ognjen

  公开号：US20080221046A1

  公开（公告）日：2008-09-11

  The present invention relates to novel semi-synthetic macrolides having anti-inflammatory activity. More particularly, the invention relates to 14- and 15-membered macrolides substituted at the 4″ position, to their pharmaceutically acceptable derivatives, to processes and intermediates for their preparation, to pharmaceutical compositions containing them and to their activity and use in the treatment of inflammatory diseases and conditions in humans and animals, especially those diseases associated with excessive secretion of TNF-α, IL-1, IL-8, IL-2 or IL-5; and/or inhibitor of excessive lymphocyte proliferation; and/or excessive granulocyte degranulation.

  本发明涉及具有抗炎活性的新型半合成大环内酯类化合物。更具体地说，该发明涉及在4″位置取代的14-和15-环大环内酯类化合物，及其药学上可接受的衍生物，用于其制备的工艺和中间体，含有它们的制剂，以及它们在治疗人类和动物的炎症性疾病和症状中的活性和用途，特别是那些与过度分泌TNF-α、IL-1、IL-8、IL-2或IL-5有关的疾病；和/或抑制过度淋巴细胞增殖；和/或过度粒细胞脱颗粒的抑制剂。